EE406 Economic Impact of Upadacitinib for the Treatment of Moderate-to-Severe Crohn’s Disease and Ulcerative Colitis: Induction and Maintenance Phase 3 Results on Work Productivity Loss
| Autor: | Yu, T, Dulai, PS, Griffith, J, Sharma, D, Loftus, EV |
|---|---|
| Zdroj: | In Value in Health June 2024 27(6) Supplement:S131-S132 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect